What is Voio?
Voio is an innovative AI healthcare company dedicated to revolutionizing medical imaging analysis. The company is developing a unified reading platform designed to empower radiologists by enabling faster and more accurate interpretation of CT, MRI, and X-ray scans. Voio's proprietary Pillar models are trained to identify hundreds of pathologies, integrating cutting-edge research with rigorous clinical validation to ultimately enhance patient care outcomes. The company's focus on improving diagnostic efficiency positions it as a key player in the rapidly evolving field of medical technology.
How much funding has Voio raised?
Voio has raised a total of $8.6M across 1 funding round:
Seed
$8.6M
Seed (2025): $8.6M with participation from The House Fund
Key Investors in Voio
The House Fund
The House Fund is a venture capital firm that invests in pre-seed and early-stage startups founded by UC Berkeley alumni, faculty, and students. By providing funding and resources, the firm aims to support and empower the next generation of innovative companies emerging from Berkeley. They offer offerings such as an AI Accelerator and the BAIR Grant to assist in advancing AI research and development. The House Fund has backed over 100 startups, including several unicorns, and seeks to connect visionary founders with key industry insights and talent.
What's next for Voio?
The recent major strategic investment signifies a pivotal moment for Voio, likely indicating a transition into a scaling phase. This capital infusion is expected to fuel further development of its AI-powered diagnostic tools, expand its market reach, and potentially support clinical trials or regulatory approvals. Voio's strategic positioning within the enterprise-level funding landscape suggests a clear path toward broader adoption and integration into healthcare systems, aiming to solidify its role in advancing radiology and patient diagnostics.
See full Voio company page
